Determination of creatinine in undiluted blood serum enzymatic flow injection analysis with optosensing

A specific enzymatic assay for creatinine in undiluted serum samples is described, exploiting the generation of ammonia from creatinine by immobilized creatinine iminohydrolase. The ammonia produced is separated from the sample matrix by gas diffusion into an acceptor stream containing a pH-sensitive indicator. The creatinine content is quantified by monitoring the resulting colour change of the indicator by means of reflectance measurement via optical fibers, the hydrophobic gas-permeable membrane serving as a diffuse reflector. Two approaches are used to overcome the interference caused by endogenous ammonia. The first is based on enzymatic abatement of endogenous ammonia by immobilized glutamate dehydrogenase. In the second, preferable, approach, endogenous ammonia, itself a parameter of clinical interest, is measured separately prior to the enzymatic degradation by creatinine iminohydrolase. Each assay requires only 30 μl of sample solution, and the sampling frequency is 60 h^?1. The relative standard deviation is approximately 3%.     

Evaluation of an enzymatic method for creatinine

Ohne Zusammenfassung

---

Evaluation of an enzymatic method for creatinine

     

Multicommutated flow analysis system for determination of creatinine in physiological fluids by Jaffe method

For the needs of photometric determination of creatinine according to Jaffe protocol a dedicated paired emitter detector diode (PEDD) detector has been developed. This PEDD device has been constructed in the compact form of flow-through cell (30 μL total volume and 7 mm optical pathlength) integrated with 505 nm LED-based emitter and 525 nm LED-based detector compatible with multicommutated flow analysis (MCFA) system. This fully mechanized MCFA system configured of microsolenoid valves and pumps is operating under microprocessor control. The developed analytical system offers determination of creatinine in the submillimolar range of concentrations with detection limit at ppm level. The throughput offered by the system operating according to multi-point fixed-time procedure for kinetic measurements is 15–40 samples per hour depending on the mode of measurements. The developed PEDD-based MCFA system has been successfully applied for the determination of creatinine in real samples of human urine as well as serum. The developed sampling unit used the system is free from effects caused by differences in sample viscosity.     

Biosensors and flow-through system for the determination of creatinine in hemodialysate

Biosensors for the determination of creatinine have been developed and integrated into a flow-through system. The sensors are based on a screen-printed three electrode transducer with a platinum working electrode. Applying the multi-enzyme sequence of creatininase (CA), creatinase (CI) and sarcosine oxidase (SO) hydrogen peroxide has been detected amperometrically. An optimal enzyme load was found to be 4.4 U/0.28 U/0.20 U (CA/CI/SO) and 0.28 U/0.20 U (CI/SO) per electrode for the creatinine sensor and for the creatine sensor, respectively. Among a variety of polymers Nafion has shown the highest efficiency to exclude interfering substances like ascorbic acid, acetaminophen and uric acid. First determinations of creatinine in dialysate samples obtained during hemodialysis treatments have shown a good correlation to the conventional methods, the Jaffé reaction (y=0.945x+ 2.8, R=0.9882, n=9) and the enzymatic photometric method (y=0.891x+3.5, R=0.9917, n=9).     

Potentiometric determination of glucose by enzymatic oxidation in a flow system

A potentiometric determination is described for glucose based on oxidation by 1,4-benzoquinone with immobilized glucose oxidase as catalyst in an enzyme reactor. The electrode is preceded by an analytical dialysis unit to remove proteins. The ratio of quinone to hydroquinone was measured with a flow-through gold electrode. Another gold electrode preceded the enzyme reactor to correct for serum components (e.g. ascorbic acid) which can also reduce quinone. The operating range is 0.04–10 × 10^-3 M β-D-glucose. The dialysis proceeds with a linear dependence on glucose concentration, and the dialysis ratio can be adjusted by changing the buffer flow rate.     

Portable microfluidic system for determination of urinary creatinine

A simple, low cost and portable microfluidic system based on a two-point alkaline picrate kinetic reaction has been developed for the determination of urinary creatinine. The creatinine reacts with picric acid under alkaline conditions, forming an orange-red colour, which is monitored on PDMS microchip using a portable miniature fibre optic spectrometer at 510 nm. A linear range was displayed from 0 to 40 mg L⁻¹ creatinine (r² = 0.997) with a detection limit of 3.3 mg L⁻¹ (S/N = 3). On-chip absorbance signals are reproducible, with relative standard deviations (RSDs) of 7.1%, when evaluated with 20 mg L⁻¹ creatinine (n = 10). The standard curves in which the intra-run CVs (4.7-6.8%) and inter-run CVs (7.9%) obtained were performed on three different days and exhibited good reproducibility. The method was highly correlated with the conventional spectrophotometric method when real urine samples were evaluated (r² = 0.948; n = 15).     

Kinetic potentiometric determination of creatinine in urine with a picrate-ion-selective electrode

A new kinetic method for the potentiometric determination of creatinine in urine based on the creatinine-picrate reaction in alkaline medium (Jaffé reaction) is described. The reaction is monitored with a picrate-selective electrode, and the increase in electrode potential within a fixed period of time (90 sec) is measured and related directly to the creatinine concentration. Analytical recovery of creatinine added to urine was 86–101% (average, 95.5%). Comparison with a spectrophotometric method gave a correlation coefficient of 0.992 over a concentration range of 0.6–2.6 g/liter.     

An enzymatic flow injection method for the determination of oxygen

An enzymatic flow injection method for the determination of dissolved oxygen is described. Oxygen from the sample is reduced quantitatively to hydrogen peroxide in a packed-bed reactor containing immobilized glucose oxidase β-d-Glucose is used as a cosubstrate. The effluent is mixed with a stream containing chromogens and fed into a second reactor containing immobilized peroxidase. The coloured product formed is monitored spectrophotometrically. The response is linear from the detection limit (2–5 μM O₂ to air-saturated samples (0.3 mM O₂) when the peak areas are plotted versus the O₂ content in the samples (50 μl). The maximum speed for 1% carry-over is 60 samples per hour and the results are available 25 s after the start of sampling. Broadening of the peak is caused by adsorption of the coloured product in the peroxidase reactor.     

Development of a fast capillary electrophoresis method for determination of creatinine in urine samples

The aim of this work was to develop a fast method using capillary electrophoresis for the determination of creatinine in human urine samples. The pH and constituents of the background electrolyte were selected by inspection of effective mobility of creatinine and candidate urine interferents versus pH curves. The tendency of the analyte to undergo electromigration dispersion and the buffer capacity were evaluated by the Peakmaster software and considered in the optimization of the background electrolyte, composed by 10 mmol L(-1) tris(hydroxymethyl)aminomethane and 20 mmol L(-1) 2-hydroxyisobutyric acid (HIBA) at pH 3.93. Separation was conducted in a fused-silica capillary (32 cm total length and 8.5 cm effective length, 50 microm I.D.), with short-end injection configuration and direct UV detection at 215 nm. The migration time of creatinine was only 22s. A few figures of merit of the method are as follows: good linearity in the concentration interval of 5-70 mg L(-1) (R(2)>0.99), limit of detection of 0.5 mg L(-1), inter-day precision better than 2.7% (n=9) and recovery in the range 99.0-103.7% at three concentration levels (50, 100 and 150 mg L(-1)). Urine samples were prepared by deproteination with acetonitrile (1:3 sample:acetonitrile, v/v), centrifugation and dilution of a deproteinated aliquot with 12.5 mmol L(-1) HIBA (1:4, v/v). Creatinine concentrations between 489 and 1063 mg L(-1) were obtained in the urine of four healthy volunteers.     

Capillary electrophoretic determination of triamterene, methotrexate, and creatinine in human urine

A capillary zone electrophoresis (CZE) method using a fused-silica capillary (60.2 cm x 75 microm ID) was investigated for the determination of triamterene (TRI), methotrexate (MTX), and creatinine (CREA) in human urine. The separation was performed using a hydrodynamic injection time of 7 s (0.5 psi), a voltage of 25 kV, a capillary temperature of 30 degrees C, and 40 mM phosphoric acid adjusted to pH 2.25 by addition of triethanolamine as separation electrolyte. Under these conditions, analysis takes about 15 min. A linear response over the 0.5-15.0 mg L(-1) concentration range was found for TRI and MTX, and 0.5-80.0 mg L(-1) for CREA. Dilution of the sample (water:urine, 1:1 for TRI and MTX, and 1:25 for CREA determination) was the only step necessary prior to analysis by electrophoresis. The developed method is easy, rapid, and sensitive and has been applied to determine triamterene,methotrexate, and creatinine in urine samples with satisfactory results.     

Simultaneous determination of uric acid and creatinine in urine by an eco-friendly solvent-free high performance liquid chromatographic method

A simple, rapid, and eco-friendly analytical method for simultaneous determination of uric acid and creatinine in urine applying high performance liquid chromatography (HPLC) is described. After dilution, de-protein, and filtration, the sample solution was injected to separate the species with C-18 column by an eluent containing 0.05 M ammonium phosphate buffer at pH 7.4. An UV detector was used to monitor the separation of species at 235 nm. Optimum conditions for separation and detection were investigated. Results indicated that under optimized condition measurements were achieved within 13 min. The detection limits were 0.127 and 0.156 mug ml(-1) for uric acid and creatinine respectively. The recovery was 95% (0.57% RSD) for uric acid and 99.2% (0.98% RSD) for creatinine, from five measurements. Real urine specimens were tested.     

Automatic flow system for the sequential determination of copper in serum and urine by flame atomic absorption spectrometry

In this work, a fully automated flow system exploiting the advantages of the association of multi-pumping, multicommutation, binary sampling and merging zones, to accomplish the sequential determination of copper in serum and urine by flame atomic absorption spectrometry, is described. The developed flow system allowed multiple tasks, such as serum samples preparation (samples and standard solutions viscosity adjustment), serum copper (SCu) measurement, urine copper (UCu) pre-concentration and its subsequent elution and measurement, to be carried out sequentially. The implemented flow manifold presented a modular configuration consisting on two quasi-independent modules, each one accountable for a specific sample manipulation and whose combined operation under computer control enabled the determination of copper in a wide concentrations range.Once optimised and with a sample consumption of about 0.250 mL of serum and 7 mL of urine, the developed flow system allowed linear calibration plots up to 5 mg L⁻¹ with a detection limit of 0.035 mg L⁻¹ for SCu and linear calibration plots up to 300 μg L⁻¹ with a detection limit of 0.67 μg L⁻¹ for UCu. The sampling rate varied according to the module employed and was about 360 determinations h⁻¹ (SCu module), 12 determinations h⁻¹ (UCu module) or 24 determinations h⁻¹ (12 urine and 12 serum samples; UCu and SCu modules simultaneously). Repeatability studies (R.S.D.%, n = 10) showed good precision for UCu at concentrations of 25 μg L⁻¹ (2.54%), 50 μg L⁻¹ (0.90%) and 100 μg L⁻¹ (1.62%) as well as for SCu at concentrations of 0.25 mg L⁻¹ (8.11%), 1 mg L⁻¹ (3.11%) and 5 mg L⁻¹ (0.90%). A comparative evaluation showed a good agreement between the results obtained in the analysis of UCu and SCu (n = 18) by both the developed methodology and the reference procedures. Accuracy was further evaluated by means of the analysis of reference samples (Seronorm™ Trace Elements Urine and Seronorm™ Trace Elements Serum) and the obtained results complied with the certified values.     

Continuous-flow potentiometric determination of creatinine in urine with a picrate ion-selective electrode

A completely automated potentiometric method for the determination of creatinine in urine is described. Creatinine reacts with picrate in alkaline media (Jaffé reaction) in a flow system, and the decrease in picrate activity is continuously monitored with a picrateselective flow-through electrode. Creatinine in urine, in the range 0.5–3 g/liter, was determined in a sample volume of 0.15 ml, with a relative standard deviation of about 1%. Forty samples per hour can be analyzed without previous dilution or pretreatment. Recovery of creatinine added to urine samples ranged from 90 to 111% with an average of 96.7%. The method compares favorably with a photometric method. The proposed automated method is suitable for routine clinical measurements and screening tests.     

高效毛细管区带电泳法快速测定尿液中的肌酐

建立了一种快速测定尿中肌酐浓度的高效毛细管电泳方法。利用非涂层石英毛细管(64.5 cm×50μm i.d),以pH 2.5,0.1 mmol/L H3PO4作为电泳缓冲液,检测波长191 nm,用0.05 Pa压力进样4 s,在电压16 kV快速分离尿液中的肌酐,采用外标法定量。肌酐的迁移时间约为5.5 min,肌酐浓度在34.5~8840μmol/L范围内呈良好的线性(r2=0.999)。平均日内精密度为2.5%,日间精密度为3.0%。回收率94.1%~99.0%。与全自动生化分析仪碱性苦味酸速率法相比有良好的相关性(r=0.990,n=56)。高效毛细管电泳法测定尿肌酐可应用于临床样品的检测。     

Continuous-flow enzymatic determination of creatinine with improved on-line removal of endogenous ammonia

A new continuous-flow automated enzymatic method suitable for the direct determination of creatinine in physiological samples is described. The proposed system utilizes an on-line gas predialysis unit in conjuction with a flow-through enzyme reactor coil and a potentiometric ammonia detector. The enzyme reactor contains immobilized creatinine iminohydrolase (EC 3.5.4.21) which converts creatinine to ammonia and N-methylhydantoin. Ammonia liberated from this reaction is detected downstream with the membrane electrode-based detector. The novel gas predialysis unit effectively removes >99.8% of endogenous ammonia (up to 1 mM) present in the sample. Thus, final peak potentials recorded by the electrode detector are directly proportional to the logarithm of creatinine concentrations present. The method is shown to be precise (<3%), selective, and capable of accurately determining creatinine in serum and urine samples containing abnormally high endogenous ammonia levels. Determinations of creatinine in serum samples (n = 30) using this new method correlate well with an existing Technicon AutoAnalyzer colorimetric method (r = 0.996).     

Multicommutation in flow analysis. Part 3. Spectrophotometric kinetic determination of creatinine in urine exploiting a novel zone sampling approach

Zone sampling performed on a single analytical channel and associated with the stopped-flow approach was proposed and applied to the spectrophotometric kinetic determination of creatinine in urine based on Jaffé's reaction. The flow network comprised microcomputer controlled three-way solenoid valves. With multicommutation, the potentialities of zone sampling and stopped-flow were expanded, and the design of the flow set up was simplified. Influence of the main related parameters such as system configuration, reagent concentrations, temperature and timing were studied. The proposed system handled about 24 samples per hour. Baseline drift was not observed during extended operation periods (8 h). Sample pretreatment was not required. Results were reproducible (R.S.D. < 3%) and in agreement with those obtained in a batch procedure.     

Extraction--spectrophotometric determination of oxalate in urine and blood serum

An extraction--spectrophotometric method is described for the determination of oxalate, based on the formation of a mixed ligand vanadium (V)--mandelohydroxamic acid--oxalate complex. The complex was extracted into a solution of trioctylmethylammonium chloride (Adogen 446) in toluene and the absorbance measured at 535 nm. The experimental variables and interferences in this determination were studied. The detection limit is 0.5 microgram ml-1 and the range of application is between 2 and 8 micrograms ml-1. The method was applied to the determination of oxalate in urine and blood serum.